ATE320266T1 - Induktion von antigen-spezifischen t-zellen durch interferon - Google Patents

Induktion von antigen-spezifischen t-zellen durch interferon

Info

Publication number
ATE320266T1
ATE320266T1 AT00306263T AT00306263T ATE320266T1 AT E320266 T1 ATE320266 T1 AT E320266T1 AT 00306263 T AT00306263 T AT 00306263T AT 00306263 T AT00306263 T AT 00306263T AT E320266 T1 ATE320266 T1 AT E320266T1
Authority
AT
Austria
Prior art keywords
antigen
induction
cells
specific
interferon
Prior art date
Application number
AT00306263T
Other languages
English (en)
Inventor
Hideo Takasu
Masashi Gotoh
Takashi Yamaoka
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of ATE320266T1 publication Critical patent/ATE320266T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00306263T 1999-07-22 2000-07-24 Induktion von antigen-spezifischen t-zellen durch interferon ATE320266T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20768799 1999-07-22

Publications (1)

Publication Number Publication Date
ATE320266T1 true ATE320266T1 (de) 2006-04-15

Family

ID=16543925

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00306263T ATE320266T1 (de) 1999-07-22 2000-07-24 Induktion von antigen-spezifischen t-zellen durch interferon

Country Status (4)

Country Link
EP (2) EP1681064A1 (de)
AT (1) ATE320266T1 (de)
CA (1) CA2313392A1 (de)
DE (1) DE60026666T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4932199A (en) 1998-07-31 2000-02-21 Haruo Sugiyama Cancer antigens based on tumor suppressor gene wt1 product
EP1371664B1 (de) 2001-03-22 2008-01-09 International Institute of Cancer Immunology, Inc. Wti-modifiziertes peptid
EP1250933A1 (de) * 2001-04-17 2002-10-23 Istituto Superiore di Sanità Impfstoffe mit hochdosiertem Typ I IFN als Adjuvans
EP1430904A4 (de) * 2001-08-29 2005-09-14 Greenpeptide Co Ltd Desensibilisatoren
EP1556082A1 (de) * 2002-10-22 2005-07-27 Aventis Pasteur Limited Impfstoffe gegen krebs mit hochdosierten zytokinen als adjuvans
RU2546540C2 (ru) * 2011-07-06 2015-04-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский Институт гриппа" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "НИИ гриппа" Минздравсоцразвития России) Способ профилактики гриппа путем сочетанного применения интерферона гамма и инактивированной противогриппозной вакцины

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9818445D0 (en) * 1998-08-24 1998-10-21 Imp College Innovations Ltd Medicaments

Also Published As

Publication number Publication date
EP1681064A1 (de) 2006-07-19
EP1074267B1 (de) 2006-03-15
EP1074267A1 (de) 2001-02-07
DE60026666D1 (de) 2006-05-11
CA2313392A1 (en) 2001-01-22
DE60026666T2 (de) 2006-11-09

Similar Documents

Publication Publication Date Title
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
FI951138A0 (fi) Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
ATE405647T1 (de) Rekombinantes gelatin in impstoffen
DE69910580D1 (de) Von der telomerase abgeleitete antigene peptide
NL192275B (nl) Eiwit van het AIDS-virus.
ATE241014T2 (de) Hiv-2 varianten
NO971875L (no) Cathepsin 02 protease
NO995182D0 (no) Pattedyrcytokinlignende faktor 7
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
PT698216E (pt) Metodos de tipificacao do virus da hepatite c e reagentes para utilizar nestes
DE69132545D1 (de) Protein mit Cytokinaktivität, Rekombinant-DNS, Expressionsvektor und Wirtszellen zu seiner Herstellung
NO910103L (no) Non-a, non-b genomisk hepatittvirus cdna samt tilsvarendepolypeptid-antigen.
WO2001025438A3 (en) Ifn-alpha homologues
EP1147212A4 (de) T-helferzellen-epitope
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
ATE320266T1 (de) Induktion von antigen-spezifischen t-zellen durch interferon
TR199901190T2 (xx) Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler.
DE69331977D1 (de) Löslicher LDL-Rezeptor, seine Herstellung und Verwendung
FI970097L (fi) Proteiinit, jotka ovat peräisin nisäkkäiden maksasta ja niiden käyttö onkologiassa
DE69938130D1 (de) Neue peptide
OA09653A (en) Rubella peptides
NO950420L (no) Interferon endelse derav
ATE315646T1 (de) Leukocyten-aktivierender faktor
DE69328488D1 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
FR2747681B1 (fr) Complexe proteique dodecaedrique adenoviral, composition le contenant et ses applications

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties